Navigation Links
Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification
Date:11/1/2007

Provides researchers tool for 50% faster miRNA preparation with no detectable large RNA and further supports Sigma's commitment to the rapidly

developing area of RNAi

ST. LOUIS, Nov. 1 /PRNewswire-FirstCall/ -- Sigma-Aldrich(TM) (Nasdaq: SIAL) is pleased to introduce mirPremier(TM) microRNA Isolation Kit (http://www.sigma.com/mirna) for purification of miRNA from diverse biological sources. The kit provides a rapid and efficient method for purifying and enriching miRNA along with other small RNAs, allowing researchers to obtain high-quality miRNA directly from cells or tissues as rapidly and simply as a total RNA preparation.

Using mirPremier microRNA Isolation Kit, researchers can purify miRNA/small RNA from diverse biological materials, including mammalian cell cultures, animal tissues, microbial cultures and plant tissues. mirPremier also allows researchers to purify miRNA/small RNA with high yield from difficult-to-extract tissues, such as grape leaf.

The mirPremier microRNA Isolation Kit can be used for isolating total RNA if messenger RNA or other large RNAs are of interest. In addition, mirPremier microRNA Isolation Kit provides an easy-to-use protocol, allowing scientists to purify miRNA within 30 minutes.

"Timely extraction of miRNA from cells or tissues is critical for downstream applications. The mirPremier microRNA Isolation Kit provides a robust protocol for quick extraction of miRNA, making the mirPremier an ideal solution for rapid preparation of miRNA," said Dr. David Smoller, President of the Sigma-Aldrich Research Biotech Business Unit. "We're very pleased to add this new product to Sigma-Aldrich's growing MISSION(R) RNAi portfolio, as it further supports our strong commitment to the rapidly developing area of RNAi."

"Isolation of miRNA and other small RNAs using the mirPremier microRNA Isolation Kit yields a highly pure and con
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...tudy finds gene variation believed to affect circa...ealthDay News) -- New research suggests that an in...a factor in the development of bipolar disorder in...ination of the genetic makeup of 152 children with...le to major mood swings, and 140 children without ...
(Date:11/27/2009)... Biotech firm Replikins Lt... the H1N1 virus genomic data. It shows that the l... 3.7 (s.d. 4.5) during the virus,s current outbrea...vels this week of 2.0 (s.d. 0.1). The H1N1 infecti... Boston (PRWEB) November 27, 2009 ...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /P...erican professional cycling team dedicated to ethi... cycling champions, announced today that it will b... Transitions Optical as a new sponsor of the team....cturer of adaptive eyewear, offering the most adva...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Specialist manufacturers ...roducts are saving millions of dollars by bringing... process. Increasing numbers of pro-active medical...perts at the concept stage of their projects, ensu...ting design processes or potentially outdated tech...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...archers at the Harvard Medical School it is said t... chronically infected cystic fibrosis (CF) patient...which secretes proteins that cause disease in the ...ay be a cancer patient with a weakened immune syst...
...on placed new restrictions on a doctors’ role i...st any policy //that gives medical professionals ...to use harsher tactics than they would in the abs...roups and medical ethicists. They charge that doct...
...ar excuse "not tonight, I have a headache," a new ...xual activity and says that sexual desire and migr... // In fact, migraine sufferers reported hig...eagues. 'Migraine patients in general may exp...
...lthcare products Regulatory Agency (MHRA) warned t...eadings. The diabetic patients are cautioned about...d to giving readings which were far too high. Diab...nsulin resulting in hypoglycaemic coma. It is...
...in San Diego, California, Allerca, Inc., is now t...kitten, the world’s first hypoallergenic cats //.T...o are also cat lovers. Allerca sources claim ...ng. Hence these animals were not transgenic,in oth...
...s at the Johns Hopkins Bloomberg School of Public ...lar immune tactics to ward off bacterial// pathoge...wn on the different genes connected with the prote...rtant for the resistance to bacterial infection. H...
Other Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:What Ticks the Mosquito immune system? 2
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Mammography Equipm...www.reportlinker.com/p0164330/Mammography-Equipmen... incidence of breast cancer in industrialized as w...fluencing growth in the mammography market. Global...
(Date:11/25/2009)...EL HILL, N.C., Nov. 25 Cempra Phar...Fernandes, president and chief executive officer, ...th Care Conference at 8:50 a.m. EST, December 1, 2.... Dr. Fernandes will provide an overview of the c...for the treatment of drug-resistant pathogens incl...
(Date:11/25/2009)...VIEW, Calif., Nov. 25 ChemoCentr...al data from the Company,s PROTECT-1 (the Prospect...disease Trial) of Traficet-EN(TM) (CCX282-B) in pa...onstrated clinical efficacy with a favorable safet...d evidence of clinical efficacy in the reduction o...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Are breast cancer patients being kept in the dark 3F 50933 1Are breast cancer patients being kept in the dark 3F 50933 2One step closer to an artificial nerve cell 50931 1One step closer to an artificial nerve cell 50931 2Severe COPD may lead to cognitive impairment 50929 1Severe COPD may lead to cognitive impairment 50929 2Severe COPD may lead to cognitive impairment 50929 3
..." Study Also Showed Arzoxifene Significantly Suppr...ostmenopausal Women with Osteoporosis , , ATHENS,...LLY ) presented new data showing arzoxifene, an in...r (SERM), was superior to raloxifene at increasing...otal hip and femoral neck, and at suppressing bone...
...20 Santaris Pharma announced today that,the fourt... In the USA,several patients with cancer have now ..., which is jointly developed by Santaris Pharma an...ministration (FDA) recently,accepted Enzon PharmaÂ...tion,for the use of the LNA-based Survivin inhibit...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: